Leki przeciwkrzepliwe u hospitalizowanych pacjentów z COVID-19: nowe dane

Andrew B. Dicks; Ido Weinberg, M. Further Evidence Supporting the Use of Prophylactic Anticoagulation in Hospitalized Patients With COVID-19. JAMA Netw Open. 2021;4(6):e2112403

Despite the limitations, this study (especially in the context of other published data) should make clinicians more confident that the use of prophylactic anticoagulation is warranted for hospitalized patients with COVID-19, as currently suggested by published societal guidelines. We eagerly await randomized trial data, while secretly hoping that by the time these are published we will have little need for their conclusions.

11 czerwca 2021`

0 replies on “Leki przeciwkrzepliwe u hospitalizowanych pacjentów z COVID-19: nowe dane”